Search

The FDA has approved the first-ever treatment developed for low-grade serous ovarian cancer, a rare type of ovarian cancer.

… Monday, May 12, 2025 The first drug for a rare and difficult-to-treat type of  ovarian cancer has been granted  accelerated approval by the Food and Drug Administration (FDA). The treatment, called avutometinib plus defactinib (Avmapki TM Fakzynja TM Co-pack), was developed to treat low-grade serous

Learn about how The Society of Memorial Sloan Kettering is supporting precision medicine at MSK Kids.

… Wednesday, April 1, 2020 On February 5, The Society of Memorial Sloan Kettering hosted its seventh annual Winter Lunch to support its Precision Medicine for MSK Kids initiative. More than 275 guests attended this year’s event, which was sponsored by Net-a-Porter for the fifth consecutive year, at the

Mutations in a gene called FOXA1 are responsible for a distinct class of prostate cancer tumors, MSK researchers have found.

… Wednesday, June 26, 2019 Summary Researchers at Memorial Sloan Kettering have identified molecular changes in a protein that promote a distinct type of prostate cancer. The findings suggest that this protein could be a good drug target for men with this form of the disease. Prostate cancer is not one

Antibody-drug conjugates and checkpoint inhibitors show promise as new therapies for bladder cancer.

… Monday, September 12, 2022 Promising new drugs have begun to transform the treatment of bladder (or urothelial) cancer, the sixth most common form of the disease in the U.S., and the fourth most common in men. In particular, two drug classes, antibody-drug conjugates (ADCs) and checkpoint inhibitors,

RSV is a respiratory disease that spreads in the fall and winter months. Learn about the RSV vaccines, which are approved for people ages 50 and older.

… Friday, September 13, 2024 People ages 50 to 74 who are at risk for getting very sick from RSV can get vaccinated, after talking with their doctor. People ages 75 and older should get an RSV vaccine. Mini Kamboj Mini Kamboj Mini Kamboj has answers to some frequently asked questions about the RSV vaccines

Memorial Sloan Kettering and Eureka Therapeutics recently entered into a licensing agreement with Novartis to develop a unique monoclonal antibody.

… Tuesday, January 28, 2014 Using monoclonal antibodies to fight cancer is a complex, yet promising area of study. At Memorial Sloan Kettering Cancer Center, physician-scientists have focused their attention on expanding the current therapeutic antibody repertoire, and believe a newly developed platform

An immunotherapy drug might be an effective initial treatment for people with metastatic Merkel cell carcinoma.

… Thursday, March 22, 2018 Summary Merkel cell carcinoma  is hard to treat after it has spread. A new immunotherapy drug, avelumab, was recently approved by the FDA for people with metastatic Merkel cell carcinoma who had previously received chemotherapy. Now new research suggests avelumab could be even

Learn about lung cancer in women, the links between lung cancer and smoking, the relationship between lung cancer and genetics, and the benefits of being treated at a hospital that offers many clinical trials for lung cancer.

… Friday, January 17, 2025 According to the latest statistics from the American Cancer Society, incidence rates of lung cancer are now higher in women than in men among people younger than 65 years.  Overall, though, the news about lung cancer is largely hopeful. In fact, a 2023 study  from the American

Infórmese sobre el cáncer pulmonar en mujeres, la conexión entre el cáncer pulmonar y el tabaquismo, la relación entre el cáncer pulmonar y la genética, y los beneficios de recibir tratamiento en un hospital que ofrece numerosos ensayos clínicos para el cáncer pulmonar.

… Friday, January 17, 2025 Según las estadísticas más recientes de la Sociedad Americana contra el Cáncer, las tasas de incidencia de cáncer pulmonar son ahora más altas en mujeres que en hombres entre las personas menores de 65 años.  Sin embargo, en general, las noticias sobre el cáncer pulmonar son

Tune in to today’s “MSK Science Spotlight.” The April 20 lecture, “A Single Cell Lens into the Roles of Cellular Plasticity in Development and Cancer,” will feature Dana Pe’er, PhD.

… Monday, April 20, 2020 Tune in to today’s “ MSK Science Spotlight .” The Sloan Kettering Institute’s online seminar series for the scientific community features illuminating lectures by today’s leaders in basic and translational biomedical science and reminds us all that the fight against cancer must